Kirkland has acted as the underwriters’ counsel in the offering. Everest Medicines Limited (HKSE: 1952) executed its US$448 million IPO and listing on the Hong Kong…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
